Positive Data from Phase 1b/2a Study of Pulmonary Infection Treatment
BiomX has announced positive data from a study assessing the safety and tolerability of BX004 in nine cystic patients.
Tag: bacterial lung infection
All
Latest
All
Latest
Bactiguard’s Endotracheal Tube Reduced Ventilator-associated Pneumonia
A study published in the Annals of Intensive Care shows a 53% reduction of ventilator-associated pneumonia with Bactiguard's endotracheal tube.
All
Latest
Study: The Tuberculosis Bacteria Puzzle
Researchers have long suspected that the ability of TB bacteria to remain dormant, sometimes for decades, stems from their ability to behave based upon past experience.
Hospital-acquired Infections Lower at ‘Closed’ ICUs
Rates for central line-associated blood stream infections, catheter-associated urinary tract infections and VAP were all lower after one facility transitioned to a closed ICU.
Read More
Oxygen, pH Levels May Affect Antibiotic Effectiveness in Cystic Fibrosis
Researchers discovered that tweaking factors in a CF lung model, such as pH balance and oxygen, helped eradicate pathogenic bacteria while minimizing risks of antibiotic resistance.
Read More
Nitric Oxide Effective against Mycobacterium abscessus
Inhaled nitric oxide had significant antibacterial activity against Mycobacterium abscessus (M. abscessus), which can infect the airways of patients with cystic fibrosis.
Read More
Unique Nasal Microbiome in Uncontrolled Asthma
Patients with uncontrolled asthma had a unique nasal bacteria composition that included elevated levels of Bacteroidetes, compared to nonasthmatics or asthmatics with controlled asthma.
Read More
Pneumonia Drug Could Treat MRSA in Cystic Fibrosis
A new study has found that telavancin, a current treatment for hospital-acquired pneumonia, could be a potential treatment against MRSA in patients with cystic fibrosis.
Read More
13 Ways to Combat Multidrug Resistant Organisms and Ventilator-associated Pneumonia
Respiratory therapists play a crucial role in minimizing intubated patients’ risk of exposure to MDROs and VAP by following proper protocols solutions that help prevent infections.
Read More
New and Emerging Treatment Options for MDR Bacteria
In a video for MD Magazine, researchers talk in depth about current and developing agents for...
Read More
Smart Bacteria Help Each Other Survive
New research from Lund University in Sweden shows for the first time how bacteria in the airways can help each other replenish vital iron, Science Daily reports.
Read More
Cytokine IFN-γ Helps Clear Lethal Bacteria In Cystic Fibrosis
Boosting a key immune process called autophagy with interferon gamma (IFN-γ) could help clear a lethal bacterial infection in cystic fibrosis, a new study suggests.
Read More
Fighting Waterborne Pathogens To Protect Ventilated Patients
In addition to the constant threat of ventilator-associated pneumonia, ventilated patients also face dangers from other less common hospital-acquired infections, including waterborne pathogens that can occur during humidification.
Read More
Natural Antimicrobial Exacerbates Infection In Cystic Fibrosis
An antimicrobial peptide produced by human immune cells can promote mutations in P. aeruginosa bacterium, a common cause of death in cystic fibrosis patients.
Read MoreHow Bacteria Y-Pestis Overwhelms The Lungs To Cause Pneumonic Plague
When the bacterium Yersinia pestis enters the lungs, it causes pneumonic plague, a disease that is 100 percent fatal if untreated. The way in which Y. pestis evades the immune system and kills people in a matter of days has largely confounded scientists, until now.
Read More